Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) (N-Term) Peptide
BCAR3
Reactivity: Human
BP
Sodium azide
-
- Target See all BCAR3 products
- BCAR3 (Breast Cancer Anti-Estrogen Resistance 3 (BCAR3))
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
16 amino acid peptide near the amino terminus of human BCAR3.
Human
-
Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) peptide
BCAR3 Reactivity: Human, Cow, Dog, Pig Host: Synthetic BP, Imm
-
- Application Notes
- BCAR3 peptide is used for blocking the activity of BCAR3.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- BCAR3 (Breast Cancer Anti-Estrogen Resistance 3 (BCAR3))
- Synonyms
- NSP2 Peptide, SH2D3B Peptide, AI131758 Peptide, AND-34 Peptide, BCAR3 Peptide, breast cancer anti-estrogen resistance 3 Peptide, breast cancer anti-estrogen resistance 3 L homeolog Peptide, BCAR3 Peptide, Bcar3 Peptide, bcar3 Peptide, bcar3.L Peptide
-
You are here:
